The present work evaluated the chemical composition and antiulcerogenic potential of the crude extract, fractions and pure compounds isolated of roots barks from Maytenus robusta Reiss, using different pharmacological models in mice. 3,12-Dioxofriedelane (1) and 11-hydroxylup-20 (29)-en-3-one (2) were isolated from the n-hexane fraction, and mayteine (3) and 3,7-dioxofriedelane (4) from the dichloromethane fraction. The crude extract (50, 259, 500 mg/kg), all the fractions (250 mg/kg) and cimetidine (100 mg/kg) significantly reduced the lesion index, total lesion area, and percentage of lesions, in comparison with the control group (p< 0.05), by ethanol and NSAID-induced ulcer models. All the isolated compounds also presented significant pharmacological effects at 30 mg/kg. These results show that the root bark of M. robusta may be a promising source of molecules with applicability in the treatment of gastric disorders.
LalooD., PrasadS.K., KrishnamurthyS., HemalathaS. (2013) Gastroprotective activity of ethanolic root extract of Potentilla fulgens Wall. ex Hook. Journal of Ethnopharmacology, 146, 505–514.
2.
SheenE., TriadafilopoulosG. (2011) Adverse effects of long-term proton pump inhibitor therapy. Digestive Diseases and Sciences, 56, 931–950.
3.
Schmeda-HirschmannG., YesiladaE. (2005) Traditional medicine and gastroprotective crude drugs. Journal of Ethnopharmacology, 100, 61–66.
4.
Klein-JúniorL.C., SantinJ.R., NieroR., AndradeS.F., Cechinel-FilhoV. (2012) The therapeutic lead potential of metabolites obtained from natural sources for the treatment of peptic ulcer. Phytochemistry Reviews, 11, 567–616.
5.
NieroR., MafraA.P., LenziA.C., Cechinel-FilhoV., TischerC.A., MalheirosA., SouzaM.M., YunesR.A., Delle MonacheF. (2006) A new triterpene with antinociceptive activity from Maytenus robusta.Natural Product Research, 20, 1315–1320.
6.
NieroR., AndradeS.F., Cechinel-FilhoV. (2011) A review of the ethnopharmacology, phytochemistry and pharmacology of plants of the Maytenus genus.Current Pharmaceutical Design, 17, 1851–1871.
7.
ArdilesA.E., González-RodríguezA., NúñezM.J., PerestelO.N.R., PardoV., JiménezI.A., ValverdeA.M., BazzocchiI.L. (2012) Studies of naturally occurring friedelane triterpenoids as insulin sensitizers in the treatment type 2 diabetes mellitus.Phytochemistry, 84, 116–124.
8.
DuarteM.C., TavaresJ.F., MadeiroS.A.L., CostaV.C.O., Barbosa FilhoJ.M., AgraM.F., Braz FilhoR., SilvaM.S. (2013) Maytensifolone, a new triterpene from Maytenus distichophylla Mart. ex Reissek. Journal of Brazilian Chemical Society, 24, 1697–1700.
9.
Gutiérrez-NicolásF., ObertiJ.C., RaveloA.G., Estévez-BraunAna. (2014) Agarofurans and sesquiterpene pyridine alkaloids from Maytenus spinosa.Journal of Natural Products, 77, 1853–1863.
10.
OliveiraD.M., SilvaG.D.F., DuarteL.P., Vieira FilhoS.A. (2006) Chemical constituents isolated from roots of Maytenus acanthophylla Reissek (Celastraceae). Biochemistry Systematics and Ecology, 34, 661–665.
11.
SilvaM.S., SousaD.P., De MedeirosV.M., FollyM.A.B., TavaresJ.F., Barbosa-FilhoJ.M. (2008) Alkaloid, flavonoids, and pentacyclic triterpenoids of Maytenus obtusifolia Mart. Biochemistry Systematics and Ecology, 36, 500–508.
12.
AndradeS.F., ComunelloE., NoldinV.F., Delle MonacheF., Cechinel-FilhoV., NieroR. (2008) Antiulcerogenic activity of fractions and 3,15-dioxo-21α-hydroxy friedelane isolated from Maytenus robusta (Celastraceae). Archives of Pharmacal Research, 31, 41–46.
13.
NieroR., MoserR., BusatoA.C.B., YunesR.A., ReisA., Cechinel-FilhoV. (2001) A comparative chemical study of Maytenus ilicifolia Mart. Reiss and Maytenus robusta Reiss (Celastraceae). Zeitschrift für Naturforschung C, 56, 158–161.
14.
MokokaT.A., McGawL.J., MdeeL.K., BaglaV.P., IwalewaE.O., EloffJ.N. (2013) Antimicrobial activity and cytotoxicity of triterpenes isolated from leaves of Maytenus undata (Celastraceae). BMC Complementary and Alternative Medicine, 13, 1–9.
15.
AhmedA.S., McGawL.J., EloffJ.N. (2013) Evaluation of pharmacological activities, cytotoxicity and phenolic composition of four Maytenus species used in southern African traditional medicine to treat intestinal infections and diarrhoeal diseases. BMC Complementary and Alternative Medicine, 13, 100–109.
16.
PiacenteS., Dos SantosL.C., MahmoodN., PizzaC. (2006) Triterpenes from Maytenus macrocarpa and evaluation of their anti-HIV activity, Natural Product Communications, 1, 1073–1078.
17.
BalbachA. (1980) A flora nacional na medicina doméstica. In A edificação do Lar.São Paulo, 2nd. p. 34.
18.
AndradeS.F., LemosM., ComunelloE., NoldinV.F., Cechinel-FilhoV., NieroR. (2007) Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models. Journal of Ethnopharmacology, 113, 252–257.
19.
Da SilvaL.M., BoeingT., SomensiL.B., CuryB.J., SteimbachV.M.B., SilveriaA.C.O., NieroR., Cechinel FilhoV., SantinJ.R., De AndradeS.F. (2015) Evidence of gastric ulcer healing activity of Maytenus robusta Reissek: In vitro and in vivo studies. Journal of Ethnopharmacology, 175, 75–85.
20.
RaimundoT.M., FavillaM., AndradeS.F., NieroR., MaistroE.L. (2012) Genotoxicity of the medicinal plant Maytenus robusta in mammalian cells in vivo.Genetics and Molecular Research, 11, 2847–2854.
BezerraM.Z.B., CampeloP.A., MachadoM.I.L., MatosF.J.A., Braz-FilhoR. (1994) Constituintes químicos isolados de três espécies do GêneroSclerolobium. Química Nova.17, 205–209.
23.
SilvaS.R.S., SilvaG.D.F., BarbosaL.C.A., DuarteL.P., Vieira FilhoS.A. (2005) Lupane pentacyclic triterpenes isolated from stems and branches of Maytenus imbricata.Helvita Chimica Acta, 88, 1102–1109.
24.
SousaG.F., DuarteL.P., AlcântaraA.F.C., SilvaG.D.F., Vieira-FilhoS.A., SilvaR., OliveiraD.M., TakahashiJ.A. (2012) New triterpenes from Maytenus robusta: Structural elucidation based on NMR experimental data and theoretical calculations. Molecules, 17, 13439–13456.
25.
KleinL.C.Jr, GandolfiR.B., SantinJ.R., LemosM., Cechinel FilhoV., AndradeS.F. (2010) Antiulcerogenic activity of extract, fractions, and some compounds obtained from Polygala cyparissias St. Hillaire & Moquin (Polygalaceae), Naunyn-Schmiedeberg's Archives of Pharmacology, 381, 121–126.
26.
Hiruma-LimaC.A., Spadari-BratfischR.C., Grassi-KassisseD.M., BritoA.R. (1999) Antiulcerogenic mechanisms of dehydrocrotonin, a diterpene lactone obtained from Croton cajucara.Planta Medica, 65, 325–330.
27.
NakagawaH., TakaishiY., FujimotoY., DuqueC., GarzonC., SatoM., OkamotoM., OshikawaT., AhmedS.U. (2004) Chemical constituents from the Colombian medicinal plant Maytenus laevis.Journal of Natural Products, 67, 1919–1924.
28.
BrinkerA.M., JunM., LipskyP.E., RaskinI. (2007) Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry, 68, 732–766.
